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Influence of potassium channel modulators on cognitive processes
in mice
1Carla Ghelardini, Nicoletta Galeotti & Alessandro Bartolini
Department of Preclinical and Clinical Pharmacology, Viale G.B. Morgagni 65, I-50134 Florence, Italy
1 The eect of i.c.v. administration of dierent potassium channel openers (minoxidil, pinacidil,
cromakalim) and potassium channel blockers (tetraethylammonium, apamin, charybdotoxin, gliquidone,
glibenclamide) on memory processes was evaluated in the mouse passive avoidance test.
2 The administration of minoxidil (10 mg per mouse i.c.v.), pinacidil (5 – 25 mg per mouse i.c.v.) and
cromakalim (10 – 25 mg per mouse i.c.v.) immediately after the training session produced an amnesic
eect.
3 Tetraethylammonium (TEA; 1 – 5 mg per mouse i.c.v.), apamin (10 ng per mouse i.c.v.),
charybdotoxin (1 mg per mouse i.c.v.), gliquidone (3 mg per mouse i.c.v.) and glibenclamide (1 mg per
mouse i.c.v.), administered 20 min before the training session, prevented the potassium channel opener-
induced amnesia.
4 At the highest eective doses, none of the drugs impaired motor coordination, as revealed by the rota
rod test, or modified spontaneous motility and inspection activity, as revealed by the hole board test.
5 These results suggest that the modulation of potassium channels plays an important role in the
regulation of memory processes. On this basis, the potassium channel blockers could be useful in the
treatment of cognitive deficits.
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Introduction
Several kinds of potassium channels with dierent electro-
physiological characteristics and pharmacological sensitivities
have been described in neurones (Halliwell, 1990; Aronson,
1992). In general, open potassium channels inhibit excitable
cells by drawing the membrane potential toward the potassium
equilibrium potential and away from action potential thresh-
old. Potassium channels that are tonically open set the resting
membrane potential. Stimuli that increase the activity of these
potassium channels hyperpolarize cells and lower the
eectiveness of excitatory imputs (Christie, 1995).
Hermissenda associative conditioning (Alkon et al., 1982)
and rabbit nictitating membrane conditioning (correlated with
enhanced postsynaptic responses due to persistent reduction of
voltage-dependent potassium current in hippocampal cells)
(Sanchez-Andres & Alkon, 1991) have all strongly suggested a
role for specific potassium channels in learning and memory.
Recently, it has been shown that a reversible antisense
inhibition of Shaker-like Kv1.1 potassium channel expression
impairs associative memory in mouse and rat (Meiri et al.,
1997). Etcheberrigaray et al. (1993) found that a 113 pS
tetraethylammonium (TEA)-sensitive potassium channel was
consistently absent from Alzheimer’s disease fibroblasts while
it was present in young and aged control fibroblasts. It was
observed that TEA depolarized and caused intracellular Ca2+
elevation in young and aged control fibroblasts but not in
Alzheimer’s disease fibroblasts. In patients with neurological
and psychiatric disorders such as Parkinson’s disease, senile
dementia and Huntington’s disease the signal induced by TEA
was present. Furthermore, Etcheberrigaray et al. (1994)
observed that treatment of fibroblasts with b-amyloid (10 nM)
induced the same potassium channel dysfunction previously
shown to occur specifically in fibroblasts from patients with
Alzheimer’s disease, namely the absence of a 113 pS potassium
channel.
Boakye et al. (1994) have observed a marked dierence to
the TEA response of the 115 pS potassium channels in
olfactory neuroblasts from Alzheimer’s patients in comparison
with normal donors. In control neuroblasts 115 pS potassium
channels were blocked by TEA 10 mM, whereas in Alzheimer’s
disease patients the same channel is not blocked by a dose of
TEA 10 times higher.
TEA blocks dierent types of potassium channels in
neurones including calcium-activated and voltage-dependent
potassium channels, although TEA is not selective for any
of them in particular (Cook & Quast, 1990; Halliwell, 1990).
Charybdotoxin, as well as apamin, was originally shown to
block specifically currents through the calcium-activated
potassium channel (Miller et al., 1985; Cook, 1988). In
recent years, it has become clear that charybdotoxin can
also block voltage-gated potassium channels (Stu¨hmer et al.,
1989; Strong, 1990). Sulphonylureas, such as gliquidone and
glibenclamide, block KATP potassium channels in neurones,
whereas minoxidil, pinacidil and cromakalim open the same
type (KATP) of potassium channel (Longman & Hamilton,
1992; Edwards & Weston, 1993). Since the potassium
channel functionality appears to be importantly involved in
memory processes, we thought it worthwhile to employ
potassium channel modulators to elucidate better the role of
potassium channels in cognitive processes. To this purpose
we have evaluated the eects produced by minoxidil,
pinacidil and cromakalim as potassium channel openers and
TEA, apamin, charybdotoxin, glibenclamide and gliquidone
as potassium channel blockers in the mouse passive
avoidance test.1Author for correspondence.
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Methods
Animals
Male Swiss albino mice (23 – 30 g) from the Morini (San Polo
d’Enza, Italy) breeding farm were used. Fifteen mice were
housed per cage. The cages were placed in the experimental
room 24 h before the test of acclimatization. The animals were
fed a standard laboratory diet and tap water ad libitum and
kept at 23+18C with a 12 h light/dark cycle, lights on at 7 h
00 min. All experiments were carried out according to the
guidelines of the European Community Council for experi-
mental animal care.
Intracerebroventricular injection technique
Intracerebroventricular (i.c.v.) administration was performed
under ether anaesthesia, according to the method described by
Haley and McCormick (1957). Briefly, during anaesthesia,
mice were grasped firmly by the loose skin behind the head. A
0.4 mm external diameter, hypodermic needle attached to a
10 ml syringe was inserted perpendicularly through the skull
and no more than 2 mm into the brain of the mouse, where
5 ml were then administered. The injection site was 1 mm to the
right or left from the midpoint on a line drawn through to the
anterior base of the ears. Injections were performed into the
right or left ventricle randomly. To ascertain that the drugs
were administered exactly into the cerebral ventricle, some
mice (20%) were injected with 5 ml of diluted 1:10 India ink
and their brains examined macroscopically after sectioning.
The accuracy of the injection technique was evaluated and the
percentage of correct injections was 95.
Passive-avoidance test
The test was performed according to the step-through
method described by Jarvik and Kopp (1967) with
modifications. The apparatus consisted of a two-compart-
ment acrylic box with a lighted compartment connected to a
darkened one by a guillotine door. In the original method
mice received a punishing electrical shock as soon as they
entered the dark compartment, while in our modified method,
mice, after their entry into the dark compartment, received a
punishment consisting of a fall into a cold water bath (108C).
For this purpose the dark chamber was constructed with a
pitfall floor. The latency times for entering the dark
compartment were measured in the training test and after
24 h in the retention test. Tetraethylammonium, apamin,
charybdotoxin, glibenclamide and gliquidone were injected
intracerebroventricularly (i.c.v.) 20 min before the training
session while minoxidil, pinacidil and cromakalim were
injected i.c.v. immediately after termination of the training
session. The drug administration schedule was chosen on the
basis of preliminary experiments in which the time-course for
each compound was determined. From these data it became
apparent that potassium channel openers exerted their
maximum amnesic eect when injected immediately after the
training session, whereas the potassium channel blockers
exerted their maximum antiamnesic eect when administered
20 min before the training session. The maximum entry
latency allowed in the retention session was 120 s. The degree
of memory recall of received punishment (fall into cold
water) was expressed as the dierence (D s) between retention
and training latencies.
Hole-board test
The hole-board test consisted of a 40 cm square plane with 16
flush mounted cylindrical holes (diameter 3 cm) distributed 4
by 4 in an equidistant, grid-like manner. Mice were placed on
the centre of the board one by one and allowed to move about
freely for a period of 10 min each. Two electric eyes, crossing
the plane from mid-point to mid-point of opposite sides, thus
dividing the plane into 4 equal quadrants, automatically
signalled the movement of the animals (counts in 10 min) on
the surface of the plane (locomotor activity). Miniature
photoelectric cells, in each of the 16 holes, recorded (counts
in 10 min) the exploration of the holes (exploratory activity)
by the mice.
Rota-rod test
The apparatus consisted of a base platform and a rotating rod
of 3 cm diameter with a non-slippery surface. The rod was
placed at a height of 15 cm from the base. The rod, 30 cm in
length, was divided into 5 equal sections by 6 disks. Thus, up
to 5 mice were tested simultaneously on the apparatus, with a
rod-rotating speed of 16 r.p.m. The integrity of motor
coordination was assessed on the basis of the number of falls
from the rod in 30 s according to Vaught et al. (1985). Those
mice scoring less than 3 and more than 6 falls in the pretest
were rejected (20%). The performance time was measured
before and 15, 30 and 45 min after treatment.
Drugs
The following drugs were used: minoxidil, pinacidil, tetra-
ethylammonium chloride, apamin, charybdotoxin, glibencla-
mide (RBI); D-amphetamine hydrochloride (De Angeli);
gliquidone (Boehringer Ingelheim); scopolamine hydrobro-
mide, cromakalim (Sigma).
Drugs were dissolved in isotonic (NaCl 0.9%) saline
solution, with the exception of pinacidil, glibenclamide and
gliquidone that were dissolved in a water and dimethylsulph-
oxide (DMSO) (3:1) vehicle, immediately before use. Drug
concentrations were prepared in such a way that the
necessary dose could be administered in a volume of 5 ml
per mouse by intracerebroventricular (i.c.v.) injection and
10 ml kg71 by subcutaneous (s.c.) or intraperitoneal (i.p.)
injection.
The potassium channel modulators were administered i.c.v.
(minoxidil 0.01 – 10 mg per mouse; pinacidil 2.5 – 25 mg per
mouse; tetraethylammonium chloride 0.5 – 5 mg per mouse;
glibenclamide 0.1 – 1 mg per mouse; gliquidone 1 – 3 mg per
mouse; cromakalim 1 – 25 mg per mouse) to avoid peripheral
eects. Moreover, since the compounds have limited ability at
crossing the blood brain barrier and apamin (1 – 10 ng per
mouse) and charybdotoxin (0.1 – 1 mg per mouse) are peptides
and therefore easily degradable by systemic administration, the
i.c.v. administration route appeared to be the most appro-
priate.
Statistical analysis
All experimental results are given as the mean+s.e.mean.
Analysis of variance (ANOVA), followed by Fisher’s protected
least significant dierence (PLSD) procedure for post-hoc
comparison, was used to verify significance between two
means. Data were analysed with the StatView software for the
Macintosh (1992). P values of less than 0.05 were considered
significant.
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Results
A comparison between two dierent aversive stimuli (electric
shock and fall into cold water) applied to the mouse passive
avoidance test is presented in Figure 1a. No dierence between
the entrance latency of retention and training sessions was
observed.
The amnesic eect of scopolamine (0.5 – 3 mg kg71, i.p.)
was of the same intensity in both experimental conditions
(electric and cold water shock; Figure 1b).
Amnesic eect of potassium channel openers
The dose-response curves for minoxidil (0.01 – 10 mg per
mouse, i.c.v.), pinacidil (2.5 – 25 mg per mouse, i.c.v.) and
cromakalim (1.0 – 25 mg per mouse, i.c.v.) in the mouse passive
avoidance test are shown in Figure 2. All compounds, injected
immediately after the training session, were endowed with
amnesic properties. The maximum amnesic eect of minoxidil,
cromakalim and pinacidil was reached at the dose of 10 mg per
mouse i.c.v. Higher doses of the three potassium channel
openers, because of their poor solubility in water, needed to be
dissolved in a vehicle comprising water and DMSO 3:1.
However, a stronger amnesic eect was not obtained. A dose
of cromakalim (25 mg per mouse i.c.v.) and pinacidil (25 mg per
mouse i.c.v.), higher than the maximal dose soluble in water,
produced an amnesia comparable to that obtained with the
doses soluble in water (Figure 2). The vehicle employed did not
modify the entrance latency in comparison with saline control
when given alone (Figure 2).
Prevention of amnesia by potassium channel blockers
The amnesia induced by minoxidil (10 mg per mouse i.c.v.),
pinacidil (10 mg per mouse i.c.v.) and cromakalim (25 mg per
mouse i.c.v.) was prevented, in the mouse passive avoidance
test, by pretreatment with the potassium channel blocker TEA
injected 20 min before the training session (Figure 3). TEA
(0.5 – 5 mg per mouse, i.c.v.) produced a dose-dependent
antagonism of the minoxidil-induced amnesia. A dose of
0.5 mg per mouse i.c.v. was completely ineective. TEA, at
1 mg per mouse i.c.v., partially prevented minoxidil amnesic
eect, even if the statistical significance was not reached, while
the dose of 5 mg per mouse i.c.v. enhanced the entrance latency
(D between retention and training) up to a value comparable to
that produced by control animals (Figure 3). A dose of TEA of
5 mg per mouse, i.c.v., was also able to prevent completely
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Figure 1 Comparison between two dierent aversive stimuli in the
mouse passive-avoidance test (a). Dose-response curve for eect of
scopolamine (0.5 – 3 mg kg71, i.p.) on mouse passive avoidance test
in the presence of an aversive stimulus constituted by electric shock
and by fall into cold water (b). The number of mice is indicated
inside the columns. Scopolamine was injected immediately after the
training session. *P50.05; **P50.01 in comparison with saline
controls; oP50.01 in comparison with unpunished mice.
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Figure 2 Dose-response curves for eects of minoxidil (0.01 – 10 mg,
i.c.v.), pinacidil (2.5 – 25 mg, i.c.v.) and cromakalim (1 – 25 mg, i.c.v.)
in the mouse passive avoidance test. Minoxidil, pinacidil and
cromakalim were injected immediately after the training session.
Each column represents the mean+s.e.mean of at least 12 mice.
*P50.05; **P50.01 in comparison with saline controls.
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Figure 3 Eect of TEA (0.5 – 5 mg, i.c.v.) on amnesia induced by
minoxidil (10 mg, i.c.v.), pinacidil (10 mg, i.c.v.) and cromakalim
(25 mg, i.c.v.) in the mouse passive avoidance test. TEA was
administered 20 min before the training session; minoxidil, pinacidil
and cromakalim were injected immediately after the training session.
The number of mice is indicated inside the columns. **P50.01 in
comparison with saline controls; oP50.01 in comparison with
minoxidil-, pinacidil- or cromakalim-treated mice.
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pinacidil and cromakalim amnesia (Figure 3). Contrary to
minoxidil, pinacidil amnesia was antagonized by TEA, 1 mg
per mouse i.c.v. (Figure 3). TEA did not produce any eect on
mouse passive avoidance test in comparison with saline-treated
mice when given alone (Figure 3).
Apamin (1 ng per mouse i.c.v.) and charybdotoxin (1 mg per
mouse i.c.v.), like TEA, were able to prevent both minoxidil
and pinacidil amnesia. The two potassium channel blockers, at
doses 10 times lower than those eective, were completely
devoid of any antiamnesic eect (Figure 4). At the active doses,
apamin and charybdotoxin did not enhance the entrance
latency in unamnesic mice in comparison with the control
group (Figure 4).
The administration of glibenclamide (1 mg per mouse i.c.v.)
and gliquidone (3 mg per mouse i.c.v.) antagonized the
memory disruption produced by minoxidil and pinacidil
without showing any memory facilitation activity when given
alone (Figure 5). Glibenclamide and gliquidone were
ineective at preventing minoxidil-induced amnesia at lower
doses (Figure 5).
No dierences between the entrance latencies of each group
in the training session of the passive-avoidance test were
observed (data not shown).
Eect of potassium channel modulators on mouse rota
rod and hole-board tests
It should be noted that the potassium channel openers
(minoxidil, pinacidil, cromakalim) and potassium channel
blockers (TEA, apamin, charybdotoxin, glibenclamide, gliqui-
done) under investigation elicited their modulatory eect on
cognitive processes without changing either gross behaviour or
motor coordination, as revealed by the rota-rod test (Table 1).
None of the drugs, administered at the highest active doses,
increased the number of falls from the rotating rod in
comparison with saline and vehicle-treated mice (Table 1).
The number of falls in the rota-rod test progressively
decreased, since mice learned how to balance on the rotating
rod.
The spontaneous motility and inspection activity of mice
was not modified by administration of the above-mentioned
potassium channel modulators, as revealed by the hole-board
test in comparison with saline and vehicle-treated mice (Figure
6). In the same experimental conditions D-amphetamine
(2 mg kg71, s.c.), used as a reference drug, increased both
parameters evaluated.
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Figure 4 Eect of apamin (0.1 – 1 ng, i.c.v.) and charybdotoxin
(0.1 – 1 mg, i.c.v.) on amnesia induced by minoxidil (10 mg, i.c.v.) and
pinacidil (10 mg, i.c.v.) in the mouse passive avoidance test. Apamin
and charybdotoxin were administered 20 min before the training
session; minoxidil and pinacidil were injected immediately after the
training session. The number of mice is indicated inside the columns.
**P50.01 in comparison with saline controls; oP50.01 in compar-
ison with minoxidil- or pinacidil-treated mice.
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Figure 5 Eect of glibenclamide (0.1 – 1 mg, i.c.v.) and gliquidone
(1 – 3 mg, i.c.v.) on amnesia induced by minoxidil (10 mg, i.c.v.) and
pinacidil (10 mg, i.c.v.) in the mouse passive-avoidance test.
Glibenclamide and gliquidone were administered 20 min before the
training session; minoxidil and pinacidil were injected immediately
after the training session. The number of mice is indicated inside the
columns. **P50.01 in comparison with saline controls; oP50.01 in
comparison with minoxidil- or pinacidil-treated mice.
Table 1 Eect of K+ channel modulators in the mouse rota-rod test
Number of falls in 30 s
Dose i.c.v. Before After treatment
Treatment per mouse treatment 15min 30min 45min
Saline
Vehicle
Minoxidil
Pinacidil
Cromakalim
TEA
Apamin
Charybdotoxin
Glibenclamide
Gliquidone
5ml
5ml
10mg
10mg
25mg
5mg
1 ng
1mg
1mg
3mg
3.8+0.4
3.5+0.5
4.6+0.4
4.5+0.3
3.7+0.4
4.6+0.5
4.8+0.4
5.1+0.4
3.7+0.6
4.4+0.4
2.6+0.5
2.7+0.4
2.9+0.4*
3.3+0.4
3.2+0.4
3.1+0.4
3.1+0.5
3.6+0.4
3.3+0.7
2.8+0.3
1.9+0.4*
2.3+0.5
1.5+0.3**
2.1+0.6*
1.9+0.5*
2.1+0.4*
2.4+0.5*
2.4+0.4*
1.7+0.5**
1.4+0.4**
1.6+0.3**
1.5+0.4**
1.2+0.2**
1.1+0.3**
0.9+0.3**
1.5+0.2**
1.2+0.3**
2.2+0.3*
1.4+0.5**
1.3+0.2**
Each value represents the mean+s.e.mean of 8 – 10 mice.
Vehicle: H2O+DMSO 3:1
*P<0.05, **P<0.01 in comparison with the respective pre-test value.
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Discussion
Potassium channel modulators appear to be involved in the
regulation of cognitive processes in mice. Our results demon-
strated that the administration of potassium channel openers
(minoxidil, pinacidil, cromakalim) provokes amnesia in the
mouse passive avoidance test of an intensity comparable to that
induced by the amnesic drugs scopolamine and dicyclomine
(Gualtieri et al., 1994). The potassium channel blockers (TEA,
apamin, charybdotoxin, glibenclamide, gliquidone) were able to
prevent the minoxidil- and pinacidil-induced amnesia.
In our experimental conditions, the electric shock, described
as the punishing stimulus in the original passive avoidance
method (Jarvik & Kopp, 1967), was substituted by a stimulus
consisting of a fall into cold water. Both foot shock and cold
water appeared to be aversive to the animals, since no
dierence between the memory recall of the two punishments
received was observed.
The importance of potassium channel functionality in the
regulation of memory processes was evident in T lymphocytes
from Alzheimer’s disease (SDAT) patients, in which inactivity
of the voltage-gated potassium channels was observed
(Fudeberg et al., 1984; Roberts, 1986). Later, a 113 pS TEA-
sensitive potassium channel was found to be consistently
absent from Alzheimer’s disease fibroblasts, whilst it was
present in young and aged control fibroblasts (Etcheberrigaray
et al., 1993). Boakye et al. (1994) observed a dierence in the
TEA response of the 115 pS potassium channels in olfactory
neuroblasts from Alzheimer’s patients in comparison with
normal donors.
The amnesia in mice was produced by opening the KATP
potassium channels and it was reversed by blocking KATP
potassium channels. These data are in agreement with the
observation that the mnemonic deficit observed in diabetic
patients may be due not only to the cerebrovascular
complications produced by the disease, but also by a
functional modification of KATP potassium channels (Meneilly
et al., 1993). Furthermore, the treatment of diabetic patients
with sulphonylureas provokes, simultaneously a decrease in
the glycaemic levels, and a statistically significant improvement
of neurological function (Meneilly et al., 1993). However,
prevention of the KATP potassium channel openers-induced
amnesia in the mouse passive-avoidance test is also obtained
by antagonizing other types of potassium channels, such as
voltage-gated and calcium activated channels. Therefore, in
the regulation of memory processes more than one type of
potassium channel appears to be involved.
In agreement with the findings of Deschaux & Bizot (1997),
the potassium channel blockers investigated did not enhance
cognitive abilities when given alone. However these findings
appear to be in contrast with other data in which a memory
enhancing eect of apamin was observed in an object
recognition task (Deschaux et al., 1997). The discrepancy
could be due to the fact that the blockade of calcium-activated
potassium channels produced by apamin aects learning
rather than memory and, therefore, is apparent only in an
object recognition task. It should be taken into account that
the eect of apamin was observed after an interval of 24 h, at a
time when control animals did not remember the exploration
of the objects presented in the first session.
The potassium channel modulators, at the highest doses
used, did not modify animals gross behaviour. Moreover, these
compounds did not impair motor coordination, as revealed by
the rota rod test, nor modify locomotor and inspection
activity, as indicated by the hole-board test. We can, thus,
suppose that the eects produced by potassium channel
modulators were not due to compromised behavioural
paradigms. Higher doses of potassium channel openers were
not investigated since they were not soluble in water. However,
at the doses used, the maximum amnesic eect had already
been reached. The use of a vehicle constituted by water and
DMSO 3:1 to dissolve a dose of pinacidil and cromakalim
higher than 10 mg per mouse i.c.v., did not increase the
intensity of the amnesia. With regard to the potassium channel
blockers TEA, apamin and charybdotoxin, at doses double
those able to prevent completely potassium channel opener-
induced amnesia, induced convulsions in mice.
In conclusion, these results suggest an important role played
by potassium channels in the regulation of memory processes.
The potassium channel blockers, therefore, could represent a
promising pharmacological approach for the treatment of
cognitive deficits.
The authors wish to thank Mary Forrest for linguistic revision of
the manuscript. This work was supported by grants from MURST
and CNR.
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Vehicle 5 µl, i.c.v.
Minoxidil 10 µg, i.c.v.
Pinacidil 25 µg, i.c.v.
Cromakalim 25 µg, i.c.v.
Tetraethylammonium 
5 µg, i.c.v.
Apamin 1 ng, i.c.v.
Charybdotoxin 1 µg, i.c.v.
Glibenclamide 1 µg, i.c.v.
Gliquidone 3 µg, i.c.v.
D-Amphetamine 2 mg kg–1, s.c.
a
b
Figure 6 Lack of eect of minoxidil, pinacidil, cromakalim, TEA,
apamin, charybdotoxin, glibenclamide and gliquidone on the hole-
board test in comparison with D-amphetamine; (a) locomotor activity
and (b) exploratory activity. The responses were recorded 15 – 25 min
after drug administration. The number of mice is indicated inside the
columns. **P50.01 in comparison with saline controls.
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